Hence, Hsieh et al. demonstrated that genetically or pharmacologically reducing Miro1 levels improved mitochondrial arrest, activated mitophagy, and prevented dopaminergic neurodegeneration in both iPSC-derived human neurons and fly models of PD, without significantly affecting the movement of healthy mitochondria (11, 12, 66). Here, RHOT1 is linked to Parkinson disease.